Zenas BioPharma Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

12.40

0.84 (7.27%)

At close: May 02, 2025, 2:45 PM

Zenas BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-156.99M	-37.12M	-119.28M
Depreciation & Amortization	137K	113K	78K
Stock-Based Compensation	10.82M	3.5M	737K
Other Working Capital	13.69M	-7.62M	6.88M
Other Non-Cash Items	925K	11.03M	44.85M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	25.43M	-8.04M	7.97M
Operating Cash Flow	-119.67M	-30.53M	-65.65M
Capital Expenditures	-131K	-17K	-2.2M
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-36.42M	n/a	n/a
Sales Maturities Of Investments	6M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-2M
Investing Cash Flow	-30.55M	-17K	-2.2M
Debt Repayment	n/a	20M	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	-6.06M	116K	n/a
Financial Cash Flow	412.96M	20.12M	59.39M
Net Cash Flow	262.89M	-10.35M	-8.5M
Free Cash Flow	-119.81M	-30.55M	-67.85M